Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans?
Vagally-mediated hyperinsulinemia is a common abnormality in various rodent models of genetic and hypothalamic obesity that have a high propensity for type 2 diabetes. We hypothesized that Pima Indians, a population with a high prevalence of hyperinsulinemia, obesity, and type 2 diabetes also have an increased parasympathetic drive to the pancreas. To test this, we measured plasma concentrations of insulin and pancreatic polypeptide (PP), a surrogate marker of pancreatic vagal tone, in lean and obese Pima Indian and Caucasian children (n = 43, 26P/17C, 7 +/- 1 y) and adults (n = 92, 61P/31C, 31 +/- 5 y). Pima Indian children had approximately 2-fold higher fasting insulin and 57% higher fasting PP concentrations than age- and sex-matched Caucasian children (P < .05). Although there was no difference in fasting PP concentration between Pima Indian and Caucasian adults, in response to a mixed meal, Pima Indians had a 51% higher early (30 minutes) PP concentration and 2-fold higher early insulin concentration than Caucasians (P < .05). PP concentrations at 60 minutes and 120 minutes after the meal were also markedly higher in both lean and obese Pima Indians compared with lean and obese Caucasians. These results suggest that Pima Indians may have an increased parasympathetic drive to the pancreas, which could lead to a primary hypersecretion of insulin and contribute to their high propensity for obesity and diabetes, as is the case in various rodent models of obesity.
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.
C
C
Weyer
A D
AD
Salbe
R S
RS
Lindsay
R E
RE
Pratley
C
C
Bogardus
P A
PA
Tataranni
D000328:Adult; D000886:Anthropometry; D001130:Arizona; D001724:Birth Weight; D002648:Child; D003920:Diabetes Mellitus / Q000097:blood* / Q000209:etiology; D005215:Fasting; D005260:Female; D005502:Food; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood* / Q000209:etiology; D007198:Indians, North American; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D016555:Matched-Pair Analysis; D009765:Obesity / Q000097:blood* / Q000209:etiology; D010179:Pancreas / Q000294:innervation / Q000378:metabolism*; D010191:Pancreatic Polypeptide / Q000097:blood / Q000378:metabolism*; D010275:Parasympathetic Nervous System / Q000502:physiology*; D019518:Postprandial Period; D044465:White People
D007328:Insulin; D010191:Pancreatic Polypeptide